LactoSpore (Bacillus coagulans)

LactoSpore (Bacillus coagulans MTCC 5856) is a spore-forming probiotic that produces L(+) lactic acid to support digestive health. Its spore structure allows survival through stomach acid to reach the intestines where it germinates and colonizes.

Origin & History

LactoSpore is a branded probiotic ingredient consisting of Bacillus coagulans MTCC 5856, a spore-forming bacterium originally isolated from spoiled canned milk. It is produced through controlled fermentation at 37°C, followed by centrifugation, filtration, and spray-drying at temperatures up to 115°C, then blended with maltodextrin to yield standardized spore powders at 6, 15, or 100 billion CFU/g concentrations.

Historical & Cultural Context

No traditional medicine use is documented for this ingredient. B. coagulans was first isolated from spoiled tinned milk in the early 20th century by Dr. B.W. Hammer, who named it for its milk-coagulating properties.

Health Benefits

• Gut health support through lactic acid production (99% L-form, ~3.99 g/L) - based on in vitro evidence only
• Survives gastric transit and colonizes the gut due to spore-forming properties - demonstrated in vitro
• Does not alter existing gut microbiota in healthy individuals - one safety study referenced
• Heat-stable probiotic suitable for hot beverages and processed foods - survives up to 115°C
• GRAS status confirms safety with no antibiotic resistance genes - genomic analysis

How It Works

LactoSpore produces predominantly L(+) lactic acid (99% L-form at ~3.99 g/L concentration) which creates an acidic environment that inhibits pathogenic bacteria growth. The spore-forming structure protects the bacterial cell through gastric transit, allowing germination in the alkaline intestinal environment where vegetative cells can adhere to intestinal epithelium and establish temporary colonization.

Scientific Research

The research dossier notably lacks details on key human clinical trials, RCTs, or meta-analyses for LactoSpore (B. coagulans MTCC 5856), with no PubMed PMIDs provided for human studies. Only one safety study in healthy individuals is mentioned, which found it does not alter gut microbiota, but specifics on design, sample size, or outcomes are absent.

Clinical Summary

Current evidence for LactoSpore is primarily based on in vitro studies demonstrating lactic acid production and gastric acid survival. One safety study in healthy individuals showed no adverse effects on existing gut microbiota composition. Limited human clinical trials have been conducted, with most research focusing on laboratory-based efficacy rather than clinical outcomes. The evidence base requires expansion with randomized controlled trials to establish therapeutic benefits.

Nutritional Profile

{"macronutrients": {"protein": "Not significant", "fiber": "Not significant"}, "micronutrients": {"vitamins": "Not significant", "minerals": "Not significant"}, "bioactive_compounds": {"lactic_acid": "Approximately 3.99 g/L (99% L-form)"}, "bioavailability_notes": "LactoSpore is a spore-forming probiotic, which enhances its survival through gastric transit and allows it to colonize the gut effectively. It is heat-stable, surviving temperatures up to 115\u00b0C, making it suitable for inclusion in hot beverages and processed foods."}

Preparation & Dosage

Available in powder formulations standardized to 6, 15, or 100 billion CFU/g of B. coagulans MTCC 5856 spores. No clinically studied dosage ranges are detailed in the research as human trials are not described. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other heat-stable probiotics, prebiotics (inulin, FOS), digestive enzymes, L-glutamine, zinc carnosine

Safety & Interactions

LactoSpore appears well-tolerated based on limited safety data, with one study showing no disruption to healthy gut microbiota. As a spore-forming probiotic, it may be contraindicated in severely immunocompromised individuals due to potential translocation risk. No specific drug interactions have been reported, though it may theoretically affect absorption of pH-dependent medications. Safety during pregnancy and lactation has not been established in clinical studies.